EUVIMEDEUVIMED entdecken
Crossref

CD74 accumulation in macrophages suppresses efferocytosis and exacerbates atherosclerosis by interfering with myosin II function

Rong Chen, Junqing Lin, Leye Yan, Ning Huang, Weizhu Yang, Longwang Lin, Lingting Zhang, Kun Ke

Archives of Biochemistry and Biophysics · 2026

DOI: 10.1016/j.abb.2026.111014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Rong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China. Hauptthemen laut MEDLINE: Macrophages, Atherosclerosis, Myosin Type II, Antigens, Differentiation, B-Lymphocyte. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective macrophage efferocytosis is a critical driver of the progression of inflammatory diseases such as atherosclerosis (AS), yet whether Cluster of Differentiation 74 (CD74) participates in this process remains unclear. In this study, using RAW264.7 macrophages as a model, we found that pharmacological inhibition of Cathepsin S with RO5459072 led to aberrant lysosomal accumulation of CD74 and markedly impaired efferocytosis. Mechanistically, co-immunoprecipitation (Co-IP) confirmed that CD74 forms a complex with myosin II. Under conditions of CD74 overexpression, siRNA-mediated silencing of myosin II further exacerbated the suppression of efferocytosis, accompanied by reduced myosin light chain 2 (MLC2) phosphorylation and downregulated expression of the bridging molecules MFGE8 and GAS6. In vivo, CD74 overexpression in APOE-/- mice aggravated aortic plaque burden, increased lipid deposition and collagen content, and reduced macrophage infiltration within plaques. Collectively, these findings suggest that dysregulation of the Cathepsin S-CD74-myosin II axis may impact AS progression by interfering with macrophage efferocytosis, offering a potential novel entry point for therapeutic intervention in AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesAtherosclerosisMyosin Type IIAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIAnimalsEfferocytosisMiceRAW 264.7 CellsMice, Inbred C57BL

Stichwörter der Autor:innen

AtherosclerosisCD74Cathepsin SEfferocytosisMacrophageMyosin II

Substanzen

Myosin Type IIAntigens, Differentiation, B-Lymphocyteinvariant chainHistocompatibility Antigens Class II

Autor:innen und Institutionen

  • Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China.
  • Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China. Electronic address: kekun6116@fjmu.edu.cn.

Zitieren

APA

Chen, R., Lin, J., Yan, L., Huang, N., Yang, W., Lin, L., Zhang, L., & Ke, K. (2026). CD74 accumulation in macrophages suppresses efferocytosis and exacerbates atherosclerosis by interfering with myosin II function. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2026.111014

Vancouver

Chen R, Lin J, Yan L, Huang N, Yang W, Lin L, et al. CD74 accumulation in macrophages suppresses efferocytosis and exacerbates atherosclerosis by interfering with myosin II function. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2026.111014

BibTeX
@article{Chen2026,
  author = {Chen, Rong and Lin, Junqing and Yan, Leye and Huang, Ning and Yang, Weizhu and Lin, Longwang and Zhang, Lingting and Ke, Kun},
  title = {CD74 accumulation in macrophages suppresses efferocytosis and exacerbates atherosclerosis by interfering with myosin II function},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  doi = {10.1016/j.abb.2026.111014}
}
Kostenlos starten →